You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.

Continue

Go back

NA NA

DOVATO PATIENT PROFILES

patient profile 1

SAMUEL

Living with HIV and managing hypercholesterolaemia and impaired glucose tolerance while ageing with HIV

56 years of age | Male

  • Reliably attends appointments
  • Trusting of treatment recommendations
  • Assumes current treatment is as "good as it gets"

MEDICAL HISTORY

  • HIV diagnosis: 2014
  • HIV treatment history
    • 3 prior regimens
    • Virally suppressed on TAF-based regimen
  • Other relevant history:
    • Hepatitis B negative

COMORBIDITIES

  • High cholesterol
  • Pre-diabetes

TREATMENT GOALS

  • He wants to continue enjoying his life with his partner and friends while remaining undetectable
  • He wishes to minimise any negative impacts of his HIV and comorbidities to ensure he can live a healthy life as he gets older.

Learn more about Dovato and why Dovato is a good option for patients like Samuel, Sophie and George

Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255. 

Dovato is a registered trade mark of the ViiV Healthcare group of companies or its licensor.

PM-IE-DLL-WCNT-250001 | Date of Preparation: February 2025

Welcome to GSK’s product website

Here you will find information about GSK’s medicines and vaccines

I'm a healthcare professional registered in Ireland 

Important notice: this site is intended for healthcare professionals registered in Ireland. By entering this site, you are confirming that you are a healthcare professional registered in Ireland. This site may contain promotional information.

I'm a member of the public in Ireland

Since you are not a healthcare professional, you will be re-directed to our public site.

PM-IE-NA-WCNT-230003